Drug promotion for an unlabeled indication--the case of topical tretinoin
- PMID: 7935705
- DOI: 10.1056/NEJM199411173312006
Drug promotion for an unlabeled indication--the case of topical tretinoin
Comment in
-
Drug promotion.N Engl J Med. 1995 Apr 13;332(15):1032; author reply 1033. N Engl J Med. 1995. PMID: 7794341 No abstract available.
-
Drug promotion.N Engl J Med. 1995 Apr 13;332(15):1032; author reply 1033. N Engl J Med. 1995. PMID: 7885416 No abstract available.
Similar articles
-
Differences in acne treatment prescribing patterns of pediatricians and dermatologists: an analysis of nationally representative data.Pediatr Dermatol. 2008 Nov-Dec;25(6):635-9. doi: 10.1111/j.1525-1470.2008.00790.x. Pediatr Dermatol. 2008. PMID: 19067874
-
Use of tretinoin in female health practice.Int J Fertil Womens Med. 1998 Mar-Apr;43(2):117-21. Int J Fertil Womens Med. 1998. PMID: 9609212 Review.
-
The retinoids, Part I.Nurse Pract Forum. 1995 Mar;6(1):6-7. Nurse Pract Forum. 1995. PMID: 7767133 No abstract available.
-
Treatment of acne vulgaris with topically applied erythromycin and tretinoin.Acta Derm Venereol. 1978;58(6):555-7. Acta Derm Venereol. 1978. PMID: 83088 Clinical Trial.
-
Topical tretinoin research: an historical perspective.J Int Med Res. 1990;18 Suppl 3:18C-25C. J Int Med Res. 1990. PMID: 2227083 Review.
Cited by
-
Bioactive-Based Cosmeceuticals: An Update on Emerging Trends.Molecules. 2022 Jan 27;27(3):828. doi: 10.3390/molecules27030828. Molecules. 2022. PMID: 35164093 Free PMC article. Review.
-
The impact of incremental innovation in biopharmaceuticals: drug utilisation in original and supplemental indications.Pharmacoeconomics. 2006 Dec;24 Suppl 2:69-86. doi: 10.2165/00019053-200624002-00008. Pharmacoeconomics. 2006. PMID: 23389490
-
Characteristics of materials distributed by drug companies. An evaluation of appropriateness.J Gen Intern Med. 1996 Oct;11(10):575-83. doi: 10.1007/BF02599024. J Gen Intern Med. 1996. PMID: 8945688 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources